Earnings Call Transcript Summaries

Ather Energy Ltd ATHERENERG Q1FY27 📝 Transcript · Automobile and Auto Components

Filed 07 Aug 2026

Q1 FY27 wholesale volume grew 81% to 83,000 units; registrations up 102%
First positive EBITDA quarter: Rs. 9 crore (0.8% margin) in Q1 FY27
Commodity costs up 46% over 5 quarters; Q1 gross margin 22.4% after 5.6% commodity hit
Expect AURIC Phase 1 ramp-up to 42k units/month by Q4 FY27; Phase 2 planned for future expansion
Production ramped from 24k in April to 31k in June; current capacity maxed at 35k units/month
New Aurangabad factory (AURIC) Phase 1 to add 5 lakh units capacity, doubling total to 9.2 lakh units/year by late 2026

Motherson Sumi Wiring India Limited MSUMI Q1FY27 📝 Transcript · Automobile and Auto Components

Filed 07 Aug 2026

Q1 FY27 revenue growth outpaced industry despite cost headwinds
Minimum wage hikes impacted profitability; discussions ongoing with customers for cost recovery
Copper price pass-through lag remains 3-6 months; 7% lag impact in Q1 vs 17% in Q4
EV revenue contribution at 8.5% of total sales
Greenfield plants reached break-even last quarter; margins to improve in coming quarters

Nestle India Limited NESTLEIND Q1FY27 📝 Transcript · Fast Moving Consumer Goods

Filed 07 Aug 2026

Margin outlook stable with efficiency programs offsetting inflationary pressures
Strong focus on technology and cost optimization to support growth and margin maintenance
FY26 saw 20 consecutive quarters of double-digit growth for NESCAFÉ; confectionery and nutrition segments also showing healthy growth
No immediate plans for M&A; focus remains on organic growth leveraging strong parent portfolio
Nestlé India reported accelerating volume-led growth with double-digit volume increases in recent quarters
Capital expenditure over last 5 years exceeded Rs 64bn, supporting capacity expansions

Central Depository Services (India) Limited CDSL Q1FY27 📝 Transcript · Financial Services

Filed 07 Aug 2026

Q1 FY27 standalone income INR327 Cr; net profit INR144 Cr; consolidated income INR341 Cr; net profit INR118 Cr
No forward guidance given; ISIN issuance capability in progress
Opened 58 lakh new demat accounts; total 18.59 crore accounts; ~80% market share
Market share stable but incremental demat share declined 420 bps since March
KYC pricing reset led to 20% price cut; offset by higher fetch volumes and Search API charges
Employee costs up due to year-end appraisal; tax rate at 25.17%

Computer Age Management Services Limited CAMS Q1FY27 📝 Transcript · Financial Services

Filed 07 Aug 2026

Capex: INR75 Cr on-prem expected in FY27; INR290 Cr total re-arch project capex with 10-year amortization
Yield compression largely in base; residual impact minimal; expect 2.5-3% annual yield decline
Q1 FY27 EBITDA grew 18% y-y to INR183 Cr; PAT up 17%; EBITDA margin expanded 270 bps to 46.4%
Non-MF margin at 13% in Q1; expected to reach ~17% by FY27 end
Employee headcount down 2-3% Q-o-Q; 4-5% reduction targeted for FY27, aiding margin expansion
PAT margin expected around 30-31% for FY27

ABB India Limited ABB Q1FY27 📝 Transcript · Capital Goods

Filed 07 Aug 2026

Macro uncertainties and commodity prices remain headwinds; mid-teens EBITDA margin guidance not yet comfortable
Price hikes taken twice in quarter to offset commodity inflation; lag in price pass-through expected
Capex of USD75-80 million planned to maintain 15% capacity headroom for 15-20% sales growth
Strong backlog of INR11,900 Cr; 40% of order book executable in next 2 quarters
Data center segment pipeline strong; capacity expansion underway to meet demand
Market growth driving order growth; no significant margin pressure from railways segment

Le Travenues Technology Limited IXIGO Q1FY27 📞 Audio · Consumer Services

Filed 06 Aug 2026

Aviation passenger growth expected to remain weak near-term due to capacity cuts by Air India (~20%) and Indigo (~10%) and geopolitical tensions; recovery likely post-festive season (Q3).
AI investments increase tech costs upfront; benefits expected to materialize over time but may pressure near-term margins.
AI investments to continue, focusing on product innovation and operational efficiency; tech costs front-loaded but expected to moderate as benefits scale.
Aviation capacity cuts and geopolitical tensions causing fare inflation and volume pressure, especially impacting new-to-flyer upgrades from trains/buses.
Train contribution margin improved to 37% (up from 32%), driven by market share gains and operational efficiencies.
Flight segment contribution margin declined to 39% from 42% YoY amid fare inflation and capacity cuts.

Mold-Tek Technologies Limited MOLDTECH Q1FY27 📞 Audio

Filed 06 Aug 2026

Q1 FY27 EBITDA margin surged to 19%, above prior 15% guidance, driven by automation and cost rationalization
FY27 revenue target maintained at ₹240-250 crore; FY28 target set at ₹350 crore including acquisition impact
Beryl expected to break even in Q2 FY27 and contribute $0.5-0.75 million to bottom line from Q3 FY27 onwards
Structural design firm acquisition expected by Q4 CY26 to enhance US market presence and service offering
MES electrical distribution team expanded to 20 people by Q4 FY27, supporting new Master Service Agreement with US power client
Beryl’s growth impacted by prior internal disruptions and US government funding delays; recovery expected H2 FY27

Mtar Technologies Limited MTARTECH Q1FY27 📝 Transcript · Capital Goods

Filed 06 Aug 2026

Capex INR500 Cr planned over FY27-FY28; INR35 Cr spent in Q1
Q1 FY27 revenue INR360.7 Cr +130% y-y; EBITDA INR85.1 Cr margin 23.6%
FY27 revenue growth guidance 80% with EBITDA margin ~24%, confident to exceed
Aerospace & Defense to double revenues in FY27; new facilities and NADCAP approval
Data center infra order INR45 Cr for FY27; dedicated facility setup for scale-up
Working capital days reduced to 59; target below 100 days for FY27

Signatureglobal (India) Limited SIGNATURE Q1FY27 📞 Audio · Realty

Filed 06 Aug 2026

FY27 launch guidance at Rs. 150 billion, with major launches planned in Q3 and Q4, primarily in Sector 71, Gurugram.
Monetization strategy: ~50% sales within 3-6 months post-launch, balance spread over project duration to balance price appreciation and financial closure.
Cost escalation expected at 7-8% annually, no abnormal raw material cost spikes in Q1.
Targeting Rs. 100 billion in pre-sales for FY27; Q1 achieved Rs. 20 billion (20% of target).
Collections expected to improve with project completions worth Rs. 50 billion during the year.
Planning to add 1,500-1,800 acres of land in FY27, including outside NCR.

Hyundai Motor India Ltd HYUNDAI Q1FY27 📝 Transcript · Automobile and Auto Components

Filed 06 Aug 2026

Margin impacted by production disruption, US-Iran conflict, commodity costs; EBITDA guidance 11-14% for FY27
New ICE mid-SUV launch in festive season; two new models expected to boost H2 growth and market share
Q1 FY27 total sales 178,082 vehicles, -1.3% y-y; domestic sales up 5.4%, exports down 19.6%
Export recovery expected from Q2; focus on increasing SUV mix in exports
Pune plant third shift starts Oct 2026, advancing capacity ramp-up by 2 years
Revenue flat at INR163.3bn; EBITDA INR15.1bn, margin 9.3% vs 13.3% last year

Indian Railway Finance Corporation Limited IRFC Q1FY27 📝 Transcript · Financial Services

Filed 06 Aug 2026

IRFC aims to surpass last year's disbursement of INR35,000 Cr in FY27, targeting INR5 lakh Cr AUM by year-end
NIM expected to grow ~10 bps annually, targeting 2% by FY30
Q1 slower disbursement (~INR2,000 Cr), pick-up expected in Q2-Q4
Zero NPA remains a key business proposition; focus on government-linked, low-risk assets
Diversification into metro, high-speed rail, DFC, GenCo, ports with bespoke financing solutions

MARUTI SUZUKI INDIA LTD. MARUTI Q1FY27 📝 Transcript · Automobile

Filed 06 Aug 2026

Commentary on demand trends and cost factors
Insights on revenue, margins, and market outlook
Transcript of Q1FY27 earnings call held on 31st July 2026
Management discussed financial results for quarter ended 30th June 2026
Detailed Q&A session with analysts and investors

Escorts Kubota Ltd ESCORTS Q1FY27 📝 Transcript · Capital Goods

Filed 06 Aug 2026

Construction equipment revenue INR419.6 Cr +39.2% y-y; industry growth 12-15% expected FY27; market share gains ongoing
Commodity inflation impacted margins; 5% cost increase in Q1 plus 1.5-2% expected in Q2; price hikes taken and planned
Capex guidance INR850-900 Cr FY27 including greenfield land acquisition; normal capex INR350-400 Cr
Q1 FY27 standalone revenue INR3,178.9 Cr +28% y-y; EBITDA INR355.4 Cr +9.4% y-y; margin 11.2% vs 13.1% y-y; PAT INR387.3 Cr +4% y-y (26% ex-exceptional)
Export volumes down in Q1; flat FY27 expected; growth anticipated FY28 with North America market opening
Captive finance penetration 10-12% Q1, aiming 40-50% dealers FY27 and pan-India FY28

Sun Pharmaceutical Industries Limited SUNPHARMA Q1FY27 📝 Transcript · Healthcare

Filed 06 Aug 2026

Q1 FY27 consolidated sales grew 10.1% y-y to INR151,836 million; EBITDA margin 28.9%
R&D spend at 5.4% of sales; 30% on innovative medicines; Organon acquisition on track for Q4 FY27
Management expects high single-digit revenue growth for FY27; tax rate around 27.8%
Multiple analyst queries on specialty product ramp-up and US generics outlook; management expects sustained growth but no product-wise guidance
India formulations sales grew 16%, market share increased to 8.5%; volume growth 5.4%
Innovative medicines sales up 12.8% to USD351 million; driven by ILUMYA, ODOMZO, CEQUA

Tata Steel Ltd 890144 Q1FY27 📝 Transcript

Filed 06 Aug 2026

Board approved 4.8 MTPA NINL expansion with Rs 33,873 Cr capex; commissioning expected in 48 months
Multiple analyst queries on European market pricing and regulatory challenges; management expects phased price recovery and ongoing regulatory engagement
Tata Steel reported resilient 1QFY27 with consolidated revenue Rs 60,794 Cr and EBITDA Rs 9,370 Cr, 15% margin
India crude steel production 5.76 MT; EBITDA margin 27%, above 10-year average; automotive & speciality volumes up 21% YoY
UK EBITDA losses narrowed to -£27M; tariff quota changes support price recovery; Port Talbot fire impact ~£5M EBITDA
Netherlands impacted by Direct Sheet Plant shutdown; EBITDA €4M; plant restart trial approved

Thermax Limited THERMAX Q1FY27 📝 Transcript · Capital Goods

Filed 06 Aug 2026

INR 300 crore shipment delay impacted Industrial Products profitability; commodity price rise added INR 10 crore cost
Focus on exiting low-margin government projects; aiming for 10%+ EBITDA margin in Industrial Infra
Q2-Q4 expected to show significant profitability improvement over last year
Q1 FY27 was difficult with a major INR 91 crore loss on a government project due to late engineering changes
Bio-CNG and renewable energy businesses faced losses; policy changes expected to boost bio-CNG pipeline from Q3 FY27
Order backlog strong with expected growth in Industrial Infra, Industrial Products, Chemicals, and Green Solutions

Divi's Laboratories Limited DIVISLAB Q1FY27 📝 Transcript · Healthcare

Filed 06 Aug 2026

Ongoing capex projects nearing completion; validation batches progressing
Gross margin approx. 68% in Q1; full-year margin expected near last year's level
Q1 FY27 consolidated total income ₹3,144 Cr (+24% y-y); PAT ₹902 Cr (+65% y-y)
Regulatory approvals key for commercial ramp-up of new projects
Management targets sustained double-digit revenue growth for FY27
Peptide capacity expanding with new 3,000-liter SPPS installations

Exide Industries Ltd EXIDEIND Q1FY27 📝 Transcript · Automobile and Auto Components

Filed 06 Aug 2026

Lithium-ion plant utilization target 25-30% in FY27; capacity 6 GWh Phase 1, potential expansion to 12 GWh
Lead acid battery capex INR500 Cr annually for capacity and tech upgrades; focus on bottlenecks and brownfield expansions
Standalone Q1 FY27 revenue grew 17.6% y-y; EBITDA INR655 Cr +19.5% y-y; margin 12.4%, +20 bps y-y
Export business grew 20%+; government tenders muted but expected to pick up in H2 FY27
Raw materials mostly imported currently; pilot projects with Indian suppliers underway; electrolyte expected to localize first
Price hikes of 4-6% taken in Q1; further hikes under review; cost pressures from currency and input costs

Clean Science and Technology Limited CLEAN Q1FY27 📝 Transcript · Chemicals

Filed 06 Aug 2026

Supply chain disruptions impacted volumes in Q1; improvements expected in Q2 but raw material price volatility remains
EBITDA margins expected to improve with higher grade HALS sales and operational efficiencies
Q1 FY27 consolidated revenue grew 10% y-y to INR 264 Cr; standalone revenue down 6% y-y but up 5% q-o-q to INR 203 Cr
Strategic collaboration with Swiss partner Geneus Chem for advanced HALS technology; expected INR 300-350 Cr incremental revenue over 3-4 years
Hydroquinone and catechol plant stabilized; commercial supplies ramping from Q2 FY27
Performance Chemical 2 plant expected commercial start in Q3 FY27 (Nov-Dec 2026)

🎙 Transcript Summaries